TGFB1 antibody
Quick Overview for TGFB1 antibody (ABIN199718)
Target
See all TGFB1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Specificity
- Western Blot demonstrated reactivity to either dimeric (25kD) or monomeric (12.5kD) molecules of TGF-b under non-reducing and reducing condition, respectively. Recognizes both human platelet-derived and recombinant TGF-b in enzyme-linked in ELISA.
-
Purification
- Protein G purified
-
Immunogen
-
TGF-b from human platelets.
Type of Immunogen: Purified protein -
Isotype
- IgG1 kappa
-
-
-
-
Application Notes
-
Approved: ELISA, Func, IHC, Neut, WB
Usage: Suitable for use in ELISA, Neutralization, Immunohistochemistry and Western Blot. Neutralization: Neutralizes TGF-b activity in vitro inhibition assay of CCL/64 cell growth and also neutralize the growth promoting action of TGF-b in the NRK-49F colony forming assays. The effect of microinjection of this MAb into one blastomere of two cell stage Xenopus embryos indicated that this antibody was able to neutralize effectively the bioactivity of TGF-b in vivo. Immunohistochemistry: Used to locate TGF-b within tissues. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.0, 40 % glycerol.
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles.
-
-
- TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
-
Alternative Name
- TGFB1 / TGF Beta 1
-
Background
-
Name/Gene ID: TGFB1
Family: TGF beta
Synonyms: TGFB1, CED, DPD1, Diaphyseal dysplasia 1, LAP, Latency-associated peptide, TGF Beta, TGFbeta, TGF-beta 1 protein, TGF-beta-1, TGFB -
Gene ID
- 7040
-
UniProt
- P01137
-
Pathways
- EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagy, Cancer Immune Checkpoints
Target
-